Azithromycin Ceftriaxone/cefotaxime Ciprofloxacin Shigella species Ampicillin Azithromycin Ciprofloxacin Co-trimoxazole Staphylococcus aureus Cefoxitin (MRSA) Ciprofloxacin Clindamycin (including inducible resistance) Co-trimoxazole Erythromycin Gentamicin Oxacillin (MRSA) Tetracycline Vancomycin Streptococcus pneumoniae Benzylpenicillin (invasive) Ceftriaxone/cefotaxime Meropenem Set 2: Organisms where the Acinetobacter baumannii Meropenem impact of resistance is complex substantial in hospital settings Enterobacteriaceae: Ceftriaxone/cefotaxime Enterobacter cloacae and Ciprofloxacin E. aerogenes Gentamicin Meropenem Pseudomonas aeruginosa Ceftazidime Ciprofloxacin Gentamicin/tobramycin Piperacillin–tazobactam Set 3: Organisms where Campylobacter jejuni and C. coli Moxifloxacin resistance is a marker of epidemiological resistance and/or usage Set 4: Organisms resistance Clostridium difficile Moxifloxacin will be monitored through Streptococcus agalactiae Benzylpenicillin passive surveillance, and that Clindamycin Erythromycin
Azithromycin Ceftriaxone/cefotaxime Ciprofloxacin Shigella species Ampicillin Azithromycin Ciprofloxacin Co-trimoxazole Staphylococcus aureus Cefoxitin (MRSA) Ciprofloxacin Clindamycin (including inducible resistance) Co-trimoxazole Erythromycin Gentamicin Oxacillin (MRSA) Tetracycline Vancomycin Streptococcus pneumoniae (invasive) Benzylpenicillin Ceftriaxone/cefotaxime Meropenem Set 2: Organisms where the impact of resistance is substantial in hospital settings Acinetobacter baumannii complex Meropenem Enterobacteriaceae: Enterobacter cloacae and E. aerogenes Ceftriaxone/cefotaxime Ciprofloxacin Gentamicin Meropenem Pseudomonas aeruginosa Ceftazidime Ciprofloxacin Gentamicin/tobramycin Piperacillin–tazobactam Set 3: Organisms where resistance is a marker of epidemiological resistance and/or usage Campylobacter jejuni and C. coli Moxifloxacin Set 4: Organisms resistance will be monitored through passive surveillance, and that Clostridium difficile Moxifloxacin Streptococcus agalactiae Benzylpenicillin Clindamycin Erythromycin
AURA-Preliminary-Report-Highlights-Doc-Dec-2015-Wed.docx